PubRank

Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON) (iDIAPASON)

Clinical Trial ID NCT02634411

PubWeight™ 0.75‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02634411

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996 35.00
2 A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1994 27.36
3 Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005 23.85
4 Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med 2013 20.70
5 A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014 16.05
6 Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005 9.06
7 Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010 7.61
8 Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003 4.84
9 The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006 4.60
10 Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003 4.09
11 Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991 3.79
12 Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 1972 3.49
13 The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006 2.94
14 Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 2007 2.94
15 Significance testing to establish equivalence between treatments, with special reference to data in the form of 2X2 tables. Biometrics 1977 2.87
16 Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998 2.62
17 Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest 2013 2.32
18 A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004 2.26
19 Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial. Intensive Care Med 2014 2.26
20 Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA 1999 2.16
21 Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. Am J Respir Crit Care Med 2008 2.10
22 Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996 2.06
23 Does this patient have ventilator-associated pneumonia? JAMA 2007 2.03
24 Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 2009 1.81
25 Bed occupancy and overcrowding as determinant factors in the incidence of MRSA infections within general ward settings. J Hosp Infect 2003 1.80
26 Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev 2011 1.73
27 Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008 1.66
28 Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 2002 1.62
29 Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 2010 1.39
30 A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Crit Care 2012 1.18
31 Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failure. Am J Respir Crit Care Med 2013 0.99
32 Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest 2005 0.96
33 Stable patients receiving prolonged mechanical ventilation have a high alveolar burden of bacteria. Chest 2005 0.89
34 Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PLoS One 2012 0.85
35 [Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study]. Ann Fr Anesth Reanim 2008 0.81
36 Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study. Trials 2017 0.75
Next 100